{
  "source": "Global Wire",
  "source_name": "Global Wire",
  "meta_source_name": "Global Wire",
  "source_guid": "src-global-wire",
  "trust_level": 10,
  "source_type": "NEWS_WIRE",
  "group_guid": "group-simulation",
  "event_type": "OTHER",
  "published_at": "2026-02-22T12:26:45.827820",
  "upload_as_group": "group-simulation",
  "title": "Update regarding Vitality Pharma",
  "story_body": "ROUTINE UPDATE: VITALITY PHARMA\n\nAt 08:00:00 UTC, Vitality Pharma issued a routine update regarding internal personnel changes. \n\nEffective immediately, Jane Doe assumes the role of Senior Director of Regulatory Affairs, reporting directly to Vitality Pharma's Chief Operating Officer. \n\nSeparately, Vitality Pharma's marketing division announced the launch of a revised product website for its flagship brand, with updates to product information and customer testimonials. The redesign aims to enhance user experience and provide clearer product information.\n\nAdditionally, Vitality Pharma disclosed its annual ESG report for the fiscal year ending December 31. The report highlights the company's commitment to reducing greenhouse gas emissions by 5% and increasing diversity in its workforce. The full report is available on the company's investor relations website.\n\nNo further information was provided, and no conference call or webcast is scheduled.",
  "validation_metadata": {
    "scenario": "Standard Filler",
    "base_ticker": "VIT",
    "expected_tier": "STANDARD",
    "expected_event": "OTHER",
    "expected_relevant_clients": [
      "550e8400-e29b-41d4-a716-446655440001",
      "550e8400-e29b-41d4-a716-446655440005"
    ],
    "relationship_hops": 0,
    "expected_feed_rank_range": "1-50",
    "validation_rules": {
      "min_score": 0,
      "max_score": 49,
      "expected_tier": "STANDARD",
      "must_match_event": false,
      "expected_event": "OTHER",
      "expected_entities": [],
      "expected_relevant_clients": [],
      "relationship_hops": 0,
      "expected_feed_rank_range": "1-50"
    }
  }
}